ciprofloxacin has been researched along with Pyoderma in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Pyoderma: Any purulent skin disease (Dorland, 27th ed).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Orbifloxacin tablets were administered orally to 23 dogs with superficial and/or deep staphylococcal pyoderma." | 7.73 | Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs. ( Miller, WH; Peters, J; Scott, DW, 2006) |
| "Plasma and skin concentrations of orbifloxacin (Orbax tablets, Schering-Plough Animal Health) were assessed in 14 clinically normal dogs and 14 dogs with pyoderma following oral administration of the drug at 7." | 7.71 | Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma. ( Katz, T; Kay-Mugford, PA; Ngoh, M; Simmons, R; Varma, KJ; Weingarten, AJ; White, A; Zolynas, R, 2002) |
| "Orbifloxacin tablets were administered orally to 23 dogs with superficial and/or deep staphylococcal pyoderma." | 3.73 | Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs. ( Miller, WH; Peters, J; Scott, DW, 2006) |
| "Plasma and skin concentrations of orbifloxacin (Orbax tablets, Schering-Plough Animal Health) were assessed in 14 clinically normal dogs and 14 dogs with pyoderma following oral administration of the drug at 7." | 3.71 | Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma. ( Katz, T; Kay-Mugford, PA; Ngoh, M; Simmons, R; Varma, KJ; Weingarten, AJ; White, A; Zolynas, R, 2002) |
| "Orbifloxacin was tested at different concentrations for killing rate against five isolates obtained from pyoderma cases and against a reference strain (Staphylococcus aureus ATCC 29213)." | 1.32 | In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. ( Etoré, F; Ganière, JP; Médaille, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Alorabi, M | 1 |
| Ejaz, U | 1 |
| Khoso, BK | 1 |
| Uddin, F | 1 |
| Mahmoud, SF | 1 |
| Sohail, M | 1 |
| Youssef, M | 1 |
| Kay-Mugford, PA | 1 |
| Weingarten, AJ | 1 |
| Ngoh, M | 1 |
| Zolynas, R | 1 |
| White, A | 1 |
| Katz, T | 1 |
| Simmons, R | 1 |
| Varma, KJ | 1 |
| Ganière, JP | 1 |
| Médaille, C | 1 |
| Etoré, F | 1 |
| Scott, DW | 1 |
| Peters, J | 1 |
| Miller, WH | 1 |
| Rongioletti, F | 1 |
| Semino, M | 1 |
| Drago, F | 1 |
| Blangetti, MG | 1 |
| Rebora, A | 1 |
| Sudy, E | 1 |
| Trygg, KJ | 1 |
| Madison, KC | 1 |
7 other studies available for ciprofloxacin and Pyoderma
| Article | Year |
|---|---|
Detection of Genes Encoding Microbial Surface Component Recognizing Adhesive Matrix Molecules in Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Ceftaroline; Chloramphenicol; Ciprofloxacin; C | 2023 |
Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Case-Control Studies; Chromatography, High Pre | 2002 |
In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Micro | 2004 |
Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dog Diseases; Dogs; Female; Male; Pyoderma; Staphyloc | 2006 |
Blastomycosis-like pyoderma (Pyoderma vegetans) responding to antibiotics and topical disodium chromoglycate.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cromoly | 1996 |
Pyoderma faciale: gram-negative recovery by means of needle aspiration.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Drainage; Enterobacter cloacae; Facia | 2002 |
Blastomycosis-like pyoderma caused by Pseudomonas aeruginosa: report of a case responsive to ciprofloxacin.
Topics: Aged; Aged, 80 and over; Blastomycosis; Ciprofloxacin; Humans; Male; Pseudomonas Infections; Pyoderm | 1990 |